# Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201

> **NCT07333820** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 18 (estimated)

## Conditions studied

- Malignant Neoplasm of Stomach, Unspecified

## Interventions

- **DRUG:** AB-201 Dose escalation

## Key facts

- **NCT ID:** NCT07333820
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-07
- **Final completion:** 2028-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333820, "Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07333820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*